Trial · NCT01856361
Ramipril for the Treatment of Oligospermia
NCT01856361, Not applicable, Terminated, Weill Medical College of Cornell University; results first posted 2017-06-02
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Ramipril for the Treatment of Oligospermia. Trials, record NCT01856361. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01856361
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Ramipril for the Treatment of Oligospermia
- NCT number
- NCT01856361
- Status
- Terminated
- Phases
- Not applicable
- Enrollment
- 2 participants, actual
- Lead sponsor
- Weill Medical College of Cornell University
- Conditions
- Oligospermia, Teratospermia, Asthenozoospermia, Male Infertility
- Interventions
- Ramipril, Placebo
- First posted
- 2013-05-17
- Last updated
- 2017-06-02
- Results first posted
- 2017-06-02
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Sperm Density in Infertile Men With Documented Oligospermia. | 32 weeks | |
| Secondary | Total Motile Sperm Count(TMSC), Total Sperm Count, Sperm Motility, and Morphology in the Ejaculate. | 32 weeks | The efficacy of ramipril in improving total sperm count will be evaluated, as well as, improving sperm motility, and morphology. |
| Secondary | Pregnancy Rate | 32 weeks | |
| Secondary | Hormonal Profile | 32 weeks | LH, FSH, serum testosterone, prolactin |
| Other | Seminal Angiotensin II and Serum Bradykinin Levels | 32 weeks |
Source ClinicalTrials.gov
Outcomes5
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Sperm Density in Infertile Men With Documented Oligospermia. | 32 weeks | Data was not collected on the 2 participants as the principal investigator on this trial moved to a different practice and thus the study terminated before any results could be analyzed. | ||
| SECONDARY | Total Motile Sperm Count(TMSC), Total Sperm Count, Sperm Motility, and Morphology in the Ejaculate. | 32 weeks | Data was not collected on the 2 participants as the principal investigator on this trial moved to a different practice and thus the study terminated before any results could be analyzed. | ||
| SECONDARY | Pregnancy Rate | 32 weeks | Data was not collected on the 2 participants as the principal investigator on this trial moved to a different practice and thus the study terminated before any results could be analyzed. | ||
| SECONDARY | Hormonal Profile | 32 weeks | Data was not collected on the 2 participants as the principal investigator on this trial moved to a different practice and thus the study terminated before any results could be analyzed. | ||
| OTHER_PRE_SPECIFIED | Seminal Angiotensin II and Serum Bradykinin Levels | 32 weeks | Data was not collected on the 2 participants as the principal investigator on this trial moved to a different practice and thus the study terminated before any results could be analyzed. |
Source ClinicalTrials.gov
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Ramipril | 1 | |
| Overall Study | STARTED | Placebo | 1 | |
| Overall Study | COMPLETED | Ramipril | 1 | |
| Overall Study | COMPLETED | Placebo | 1 | |
| Overall Study | NOT COMPLETED | Ramipril | 0 | |
| Overall Study | NOT COMPLETED | Placebo | 0 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Ramipril | ||
| Total, all-cause mortality | Placebo | ||
| Total, other adverse events | Ramipril | 0 | 1 |
| Total, other adverse events | Placebo | 0 | 1 |
| Total, serious adverse events | Ramipril | 0 | 1 |
| Total, serious adverse events | Placebo | 0 | 1 |
Source ClinicalTrials.gov
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons1
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison |
|---|
| Ramipril vs Placebo: serious adverse events |
Source Trial comparisons
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT01856361
GET https://conductscience.org/api/trials/v1/NCT01856361/registered